Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Acetoxymethylketobemidone

From Wikipedia, the free encyclopedia
(Redirected from O-AMKD)
Acetoxymethylketobemidone
Identifiers
  • [3-(4-acetyl-1-methylpiperidin-4-yl)phenyl] acetate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H21NO3
Molar mass275.348 g·mol−1
3D model (JSmol)
  • CC(=O)C1(CCN(CC1)C)C2=CC(=CC=C2)OC(=O)C
  • InChI=1S/C16H21NO3/c1-12(18)16(7-9-17(3)10-8-16)14-5-4-6-15(11-14)20-13(2)19/h4-6,11H,7-10H2,1-3H3
  • Key:ZXPASXBVYVTLRG-UHFFFAOYSA-N

Acetoxymethylketobemidone (O-AMKD), is an opioid designer drug related to ketobemidone, with around the same potency as morphine. It was first identified in Germany in October 2020.[1][2]

See also

[edit]

References

[edit]
  1. European Monitoring Center for Drugs and Drug Addiction (December 2020). "New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic" (PDF). An Update from the EU Early Warning System. Luxembourg: Publications Office of the European Union. doi:10.2810/921262. ISBN 9789294975584.
  2. Lamy FR, Daniulaityte R, Barratt MJ, Lokala U, Sheth A, Carlson RG (August 2021). ""Etazene, safer than heroin and fentanyl": Non-fentanyl novel synthetic opioid listings on one darknet market". Drug and Alcohol Dependence. 225 108790. doi:10.1016/j.drugalcdep.2021.108790. PMID 34091156. S2CID 235362241.